8 results
Algorithm for the Long-Term Treatment of Venous Thromboembolism 

Reference: https://doi.org/10.1182/blood.2019002364

by Dr. Clive Kearon and Dr. Susan
Algorithm for the ... Thromboembolism Reference ... SusanRKahn1 #LongTerm ... Thromboembolism #VTE ... #Anticoagulation
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... + Warfarin) Reference ... #DOAC #Dosing #Oral ... #Anticoagulation
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... risk of recurrent VTE ... with patients’ preference ... DOAC, direct oral ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... body mass index; VTE ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
►
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Vasculitis Management Algorithm ... High-Dose Daily Oral ... Options in Order of Preference ... ACR2021 #Guidelines #algorithm
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism Treatment Algorithm ... therapy - Second VTE ... blood.2019002364 #Longterm ... management #hematology #anticoagulation
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
comorbidities, and preferences ... five effective oral ... If needed or if oral ... following drugs are no longer
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE